Botanical species · safety record

Rhamnus cathartica

The EFSA Compendium of Botanicals holds 5 constituent measurements and 1 adverse-effect record for Rhamnus cathartica. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Rhamnus cathartica L.

5Constituent measurements
1Safety records
4Cited sources
18Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 18 licensed products naming Rhamnus cathartica as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

  • Aged bark
  • Bark
  • Fruit
  • Fruit(s)
  • Stem bark

What the records describe

Constituents measured

  • Anthracene derivatives2
  • Alkaloids1
  • Anthraquinones1
  • Emodin1

Plant parts

  • Fruit unspecified4
  • Aerial part of plants1
  • Roots and other underground parts1

Preparations

  • Solvent extraction5
  • Drying (dehydration)1

Effect types

  • Hepatotoxicity1

Target tissues

  • Liver1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
AlkaloidsRoots and other underground partsSolvent extraction10 Milligram/100 gramColorimetry, Spectroscopy (Spectrometry) and PhotometryNo resolvable identifier
Anthracene derivativesFruit unspecifiedSolvent extraction≤ 0.37 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
Anthracene derivativesFruit unspecifiedSolvent extraction≥ 0.31 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
AnthraquinonesFruit unspecifiedSolvent extraction14.3 Microgram/gramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
EmodinFruit unspecifiedSolvent extraction585.6 Microgram/gramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
HepatotoxicityLiverAerial part of plantsDrying (dehydration)House mouse (as animal)SubchronicNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Shmygareva, A.A., Kurkin, V.A., Sankov, A.N. Validated high-performance liquid chromatography method for quantitative determination of anthracene derivatives in decoction, syrup and water-alcohol extract of Rhamnus cathartica L. fruits. International journal of pharmacognosy and phytochemical research, 2016, vol. 8, no. 4, p. 683-685.
  2. Lichtensteiger, CA., Johnston, NA., Beasley, VR. Rhamnus cathartica (Buckthorn) hepatocellular toxicity in mice. Toxicologic pathology, 1997, vol. 25, no. 5, p. 449-452.
  3. Hultin, E., Torssell, K. Alkaloid-screening of swedish plants. Phytochemistry, 1965, vol. 4, no. 3, p. 425-433.
  4. Epifano, Francesco., Genovese, Salvatore., Kremer, Dario., Randic, Marco., Carlucci, Giuseppe., Locatelli, Marcello. Re-investigation of the Anthraquinone Pool of Rhamnus spp.: Madagascin from the Fruits of Rhamnus cathartica and R. intermedia . Natural product communications, 2012, vol. 7, no. 8, p. 1029-1032.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue